Related references
Note: Only part of the references are listed.Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
Kristin Cecilie Carlsson Petri et al.
DIABETES THERAPY (2018)
Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
Kristin Cecilie Carlsson Petri et al.
DIABETES THERAPY (2018)
Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
Stephen T. Buckley et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs
Ruba Ismail et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes
Xueying Tan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes A Randomized Clinical Trial
Melanie Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Basics and recent advances in peptide and protein drug delivery
Benjamin J. Bruno et al.
THERAPEUTIC DELIVERY (2013)
Pharmacokinetics of Oral Cyanocobalamin Formulated With Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): An Open-Label, Randomized, Single-Dose, Parallel-Group Study in Healthy Male Subjects
M. Cristina Castelli et al.
CLINICAL THERAPEUTICS (2011)
Is the oral route possible for peptide and protein drug delivery
Mariko Morishita et al.
DRUG DISCOVERY TODAY (2006)
Share Paper
